Announced
Completed
AFFERENT PHARMACEUTICALS INC / MERCK & CO / THIRD ROCK VENTURES LLC / TEKLA CAPITAL MANAGEMENT LLC / NEW LEAF VENTURE PARTNERS / DOMAIN ASSOCIATES LLC / A M PAPPAS & ASSOCIATES / Acquisition / Private / £859m
Synopsis
Sale of Afferent Pharmaceuticals, a developer of pharmaceutical treatments for osteoarthritis, back pain, visceral pain and neuropathy, to Merck & Co.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.